Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will publish the risk assessment of the Innova SARS-CoV-2 Antigen Rapid Qualitative Test as announced by the Medicines and Healthcare Products Regulatory Agency on 17 June 2021.

We are unable to publish the risk assessment requested as this is commercially sensitive. However, we are preparing to publish a summary of the assessment, which outlines the evidence considered and conclusions.